U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C4H6O6.C2H7NS
Molecular Weight 227.236
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYSTEAMINE BITARTRATE

SMILES

NCCS.O[C@H]([C@@H](O)C(O)=O)C(O)=O

InChI

InChIKey=NSKJTUFFDRENDM-ZVGUSBNCSA-N
InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
CYSTEAMINE BITARTRATE
MI   ORANGE BOOK   VANDF  
Common Name English
MERCAMINE BITARTRATE
Common Name English
CYSTEAMINE BITARTRATE [ORANGE BOOK]
Common Name English
Mercaptamine bitartrate [WHO-DD]
Common Name English
CYSTAGON
Brand Name English
CYSTEAMINE BITARTRATE [JAN]
Common Name English
ETHANETHIOL, 2-AMINO-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)
Systematic Name English
MERCAPTAMINE BITARTRATE [MART.]
Common Name English
RP-103
Code English
.BETA.-MERCAPTOETHYLAMINE HYDROGEN TARTRATE
Systematic Name English
CYSTEAMINE BITARTRATE [MI]
Common Name English
MERCAPTOETHYLAMINE BITARTRATE
Systematic Name English
MERCAPTAMINE BITARTRATE
MART.   WHO-DD  
Common Name English
CYSTEAMINE BITARTRATE [VANDF]
Common Name English
PROCYSBI
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C29701
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
EU-Orphan Drug EU/3/14/1306
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
Code System Code Type Description
CHEBI
50386
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
DAILYMED
QO84GZ3TST
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
ChEMBL
CHEMBL602
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
CAS
27761-19-9
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
SMS_ID
100000089423
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
RXCUI
81990
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY RxNorm
ECHA (EC/EINECS)
248-641-7
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
DRUG BANK
DBSALT000032
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
EPA CompTox
DTXSID801026168
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
MERCK INDEX
m4046
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY Merck Index
FDA UNII
QO84GZ3TST
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
NCI_THESAURUS
C47467
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
EVMPD
SUB03168MIG
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
PUBCHEM
11958147
Created by admin on Fri Dec 15 15:58:57 UTC 2023 , Edited by admin on Fri Dec 15 15:58:57 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of CYSTEAMINE
PARENT (SALT/SOLVATE)
Structure of TARTARIC ACID
SALT/SOLVATE (SALT/SOLVATE)
Structure of CYSTEAMINE BITARTRATE MONOHYDRATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966